Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Inflammatory eye disorders
•
Pediatric Rheumatology
What is your recommended rheumatic disease evaluation for a pediatric patient presenting with interstitial keratitis and a negative infectious disease workup (e.g., HSV, syphilis, Lyme)?
Related Questions
Is there a benefit to having a transition period in which a patient continues following with their previous pediatric rheumatologist while establishing care with a new adult rheumatologist?
Do you recommend adjusted adult cancer screening for patients who have been on long term biologics and/or tsDMARDs since childhood?
What are some strategies to help teach patients transitioning from pediatric to adult care to become more independent with respect to their care and less dependent on their caregivers?
In a young patient who was vaccinated to chickenpox as a child (no previous varicella infection) should the patient receive a shingles vaccine prior to starting Rinvoq?
What is your approach to screening patients with sJIA for associated lung disease?
Do you continue TNF inhibitors in patients with a new diagnosis of CLL?
What is your treatment approach for bilateral peripheral ulcerative keratitis that has been resistant to topical treatment in a patient with negative infectious and autoimmune workup?
What are some of the biggest challenges you run into when patients transition from pediatric to adult care?
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
How would you approach management of a patient with sJIA that was previously well controlled on tocilizumab but is now having ongoing joint disease activity?
